Roivant Sciences Stock Performance
as on September 30, 2026 at 2:15 pm IST
Day's Low
Day's High
$35.75$37.31
2.05%
Downside
2.22%
Upside
52 Week's Low
52 Week's High
$14.93$42.5059.11%
Downside
16.44%
Upside
Roivant Sciences share price movements today
- Previous Close
- $36.98
- Open
- $37.14
- Volume
- 4.7M
- Market Cap
- $26.7B
- Day's Low - High
- $35.75 - $37.31
- 52 Week Low - High
- $14.93 - $42.50
Roivant Sciences Historical Returns
- 1 Month Return
- + 5.16 %
- 3 Month Return
- + 3.14 %
- 1 Year Return
- + 141.24 %
- 3 Year Return
- + 212.5 %
- 5 Year Return
- 0 %
Roivant Sciences Stock Fundamentals & Key Indicators
Check Roivant Sciences market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$26.7B
EPS (TTM)
-0.38
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
-0.96%
PE Ratio (TTM)
-97.32
Industry PE ratio
11.41
PEG Ratio
0.81
EBITDA
-281.3M
Revenue (TTM)
7.5M
Profit Margin
81.21%
Return On Equity TTM
-6.12%
Roivant Sciences vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Roivant Sciences with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| StrongBuy | $26.7B | NA | -97.32 | 81.21% | 0.00% | |
| StrongBuy | $43.2B | 643.29% | -22.77 | 0.00% | 0.00% | |
| Neutral | $78.8B | -47.13% | -24.72 | -12.57% | 0.00% | |
| StrongBuy | $133.4B | 189.75% | 30.38 | 86.04% | 0.00% | |
| Buy | $81.1B | 24.01% | 17.96 | 84.86% | 0.49% |
Stock Returns calculator for Roivant Sciences Stock including INR - Dollar returns
The Roivant Sciences stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Roivant Sciences investment value today
Current value as on today
₹2,60,221
Returns
₹1,60,221
(+160.22%)
Returns from Roivant Sciences Stock
₹1,41,243 (+141.24%)
Dollar Impact
₹18,978 (+18.98%)
Analyst Recommendation on Roivant Sciences Stock
Based on 8 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
Based on 8 analysts, 100% of analysts recommend a 'BUY' rating for Roivant Sciences. Average target price of $48.08
Roivant Sciences Share Price Target
Get share price movements and forecasts by analysts on Roivant Sciences.
What analysts predicted
24.08%UPSIDE
Target Price
$48.08
Current Price
$36.5
Analyzed by
8 Analysts
Target
$48.08
Roivant Sciences target price $48.08, a slight upside of 24.08% compared to current price of $36.5. According to 8 analysts rating.
Indian Investors' Interest in Roivant Sciences Stock
Investment in Roivant Sciences Shares on INDmoney has grown by 459.25% in the last 30 days, indicating increased investment activity.
Time period: to
Change:459.25% versus previous 30 day period
Search interest for Roivant Sciences Stock has increased by 462% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:462% versus previous 30 day period
Roivant Sciences Quarterly Profit & Loss
All numbers in Millions USD
Roivant Sciences Annual Profit & Loss
All numbers in Millions USD
Roivant Sciences Quarterly Cash Flow
All numbers in Millions USD
Roivant Sciences Annual Cash Flow
All numbers in Millions USD
Roivant Sciences News & Key Events
Today's Timeline - 08 September
Tue, 07:19 PM
-Roivant announced positive Phase 2 results for mosliciguat, showing significant reductions in pulmonary vascular resistance.
Tue, 08:30 PM
-Jefferies raised Roivant's price target to $52, highlighting impressive Phase 2 trial data for mosliciguat.
Tue, 10:05 PM
-H.C. Wainwright raised Roivant's price target to $47, citing strong Phase 2 trial results for mosliciguat.
Today's Timeline - 08 September
Tue, 10:15 PM
-Shares rallied 20% after positive Phase 2 trial results for mosliciguat in pulmonary hypertension patients.
Insights on Roivant Sciences
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTBest in 3 Years
In the last 3 years, ROIV has outperformed top 5 stocks with highest market-cap in its industry
- POSITIVE IMPACT
Price Rise
In the last 1 year, ROIV stock has moved up by 141.2%
NO EFFECTAgainst Peers
In the last 1 year, Moderna, Inc. Common Stock has given 687.7% return, outperforming this stock by 546.5%
NEGATIVE IMPACTProfit Down
Netprofit is down for the last 2 quarters, 302.99M → -189.83M (in $), with an average decrease of 162.7% per quarter
- NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 2.52M → 1.44M (in $), with an average decrease of 42.8% per quarter
About Roivant Sciences
| Organisation | Roivant Sciences |
| Headquarters | 50 Broadway, London, GL, SW1H 0DB, GB |
| Industry | Biotechnology |
| CEO | Matthew Gline |
Key Management of Roivant Sciences
Name | Title |
|---|---|
Dr. Eric Venker M.D., Pharm.D. | President & CEO of Immunovant |
Dr. Mayukh Sukhatme M.D. | President, Chief Investment Officer & Director |
Dr. Frank M. Torti M.B.A., M.D. | President & Vant Chair |
Ms. Jennifer Humes | Chief Accounting Officer |
Mr. Ian Rosenblum | Chief Information Officer |
Mr. Sam Kaplan | General Counsel |
Ms. Kelly Graff | Head of People |
Mr. Matthew Gline | CEO & Director |
Mr. Richard Pulik | Chief Financial Officer |
Mr. Alex Gasner | Executive Vice President of Roivant Health |
FAQs
What is Roivant Sciences share price today?
Roivant Sciences share price today is $36.50 as on at the close of the market. Roivant Sciences share today touched a day high of $37.31 and a low of $35.75.
What is the 52 week high and 52 week low for Roivant Sciences share?
Roivant Sciences share touched a 52 week high of $42.50 on and a 52 week low of $14.93 on . Roivant Sciences stock price today i.e. is closed at $36.50,which is 14.12% down from its 52 week high and 144.56% up from its 52 week low.
What is Roivant Sciences's market capitalisation today?
Roivant Sciences market capitalisation is $0.03T as on .
How to invest in Roivant Sciences Stock (ROIV) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Roivant Sciences on INDmoney app. Click on Buy button.
What is the minimum amount required to buy Roivant Sciences Stock (ROIV) from India?
Indian investors can start investing in Roivant Sciences (ROIV) shares with as little as ₹95.83000183105469 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹958.30 in Roivant Sciences stock (as per the Rupee-Dollar exchange rate as on ).
Based on Roivant Sciences share’s latest price of $36.50 as on September 30, 2026 at 8:45 am IST, you will get 0.2740 shares of Roivant Sciences. Learn more about
fractional shares .